 Allergen immunotherapy Allergic rhinitis Allergen Allergy Sublingual administration Immunotherapy Timothy-grass Allergic conjunctivitis Pollen Medicine Allergology Immunology | |  Summary Basis for Regulatory Action Date: April 11, 2014 From: Jon R. Daugherty, Ph.D., Chair of the Review Committee BLA/STN#: [removed]Applicant Name: Merck Sharp & Dohme Corporation Date of Submission: January 25, 2013
Add to Reading ListSource URL: www.fda.govDownload Document from Source Website File Size: 190,81 KBShare Document on Facebook
|
